277 related articles for article (PubMed ID: 11422740)
1. Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.
Panichi V; Migliori M; Taccola D; Filippi C; De Nisco L; Giovannini L; Palla R; Tetta C; Camussi G
Kidney Int; 2001 Jul; 60(1):87-95. PubMed ID: 11422740
[TBL] [Abstract][Full Text] [Related]
2. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
[TBL] [Abstract][Full Text] [Related]
3. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis.
Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis.
Yoshimura A; Inui K; Nemoto T; Uda S; Sugenoya Y; Watanabe S; Yokota N; Taira T; Iwasaki S; Ideura T
J Am Soc Nephrol; 1998 Nov; 9(11):2027-39. PubMed ID: 9808088
[TBL] [Abstract][Full Text] [Related]
5. Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative.
Daniel C; Ziswiler R; Frey B; Pfister M; Marti HP
Exp Nephrol; 2000; 8(1):52-62. PubMed ID: 10644883
[TBL] [Abstract][Full Text] [Related]
6. Platelet-complement interactions in mesangial proliferative nephritis in the rat.
Johnson RJ; Pritzl P; Iida H; Alpers CE
Am J Pathol; 1991 Feb; 138(2):313-21. PubMed ID: 1704189
[TBL] [Abstract][Full Text] [Related]
7. Effect of simvastatin on proliferative nephritis and cell-cycle protein expression.
Yoshimura A; Nemoto T; Sugenoya Y; Inui K; Watanabe S; Inoue Y; Sharif S; Yokota N; Uda S; Morita H; Ideura T
Kidney Int Suppl; 1999 Jul; 71():S84-7. PubMed ID: 10412745
[TBL] [Abstract][Full Text] [Related]
8. Distinctive roles of neutrophils and monocytes in anti-thy-1 nephritis.
Westerhuis R; van Straaten SC; van Dixhoorn MG; van Rooijen N; Verhagen NA; Dijkstra CD; de Heer E; Daha MR
Am J Pathol; 2000 Jan; 156(1):303-10. PubMed ID: 10623679
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
[TBL] [Abstract][Full Text] [Related]
10. Thrombospondin peptides are potent inhibitors of mesangial and glomerular endothelial cell proliferation in vitro and in vivo.
Hugo CP; Pichler RP; Schulze-Lohoff E; Pröls F; Adler S; Krutsch HC; Murphy-Ullrich JE; Couser WG; Roberts DD; Johnson RJ
Kidney Int; 1999 Jun; 55(6):2236-49. PubMed ID: 10354272
[TBL] [Abstract][Full Text] [Related]
11. Mesangial proliferative glomerulonephritis induced in rats by a lentil lectin and its antibodies.
Sekiyama S; Yoshida F; Yuzawa Y; Fukatsu A; Suzuki N; Sakamoto N; Matsuo S
J Lab Clin Med; 1993 Jan; 121(1):71-82. PubMed ID: 8426083
[TBL] [Abstract][Full Text] [Related]
12. Platelets mediate glomerular cell proliferation in immune complex nephritis induced by anti-mesangial cell antibodies in the rat.
Johnson RJ; Garcia RL; Pritzl P; Alpers CE
Am J Pathol; 1990 Feb; 136(2):369-74. PubMed ID: 1968315
[TBL] [Abstract][Full Text] [Related]
13. Effect of acteoside on mesangial proliferation in rat anti-Thy 1 nephritis.
Hattori T; Fujitsuka N; Shindo S
Nihon Jinzo Gakkai Shi; 1996 May; 38(5):202-12. PubMed ID: 8699610
[TBL] [Abstract][Full Text] [Related]
14. Modulation of experimental mesangial proliferative nephritis by interferon-gamma.
Johnson RJ; Lombardi D; Eng E; Gordon K; Alpers CE; Pritzl P; Floege J; Young B; Pippin J; Couser WG
Kidney Int; 1995 Jan; 47(1):62-9. PubMed ID: 7731171
[TBL] [Abstract][Full Text] [Related]
15. Recovery of damaged glomerular capillary network with endothelial cell apoptosis in experimental proliferative glomerulonephritis.
Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N
Nephron; 1998; 79(2):206-14. PubMed ID: 9647502
[TBL] [Abstract][Full Text] [Related]
16. [Expression of FGF2, FGF receptor-1 and alpha-smooth muscle actin in experimental mesangial proliferative nephritis].
Jyo Y
Nihon Jinzo Gakkai Shi; 1996 Dec; 38(12):545-54. PubMed ID: 9014473
[TBL] [Abstract][Full Text] [Related]
17. Treatment of experimental mesangioproliferative glomerulonephritis with non-anticoagulant heparin: therapeutic efficacy and safety.
Burg M; Ostendorf T; Mooney A; Koch KM; Floege J
Lab Invest; 1997 Apr; 76(4):505-16. PubMed ID: 9111513
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-10 inhibits experimental mesangial proliferative glomerulonephritis.
Kitching AR; Katerelos M; Mudge SJ; Tipping PG; Power DA; Holdsworth SR
Clin Exp Immunol; 2002 Apr; 128(1):36-43. PubMed ID: 11982588
[TBL] [Abstract][Full Text] [Related]
19. Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with Roscovitine, a novel cyclin-dependent kinase antagonist.
Pippin JW; Qu Q; Meijer L; Shankland SJ
J Clin Invest; 1997 Nov; 100(10):2512-20. PubMed ID: 9366565
[TBL] [Abstract][Full Text] [Related]
20. Experimental mesangial proliferative glomerulonephritis (the anti-Thy-1.1 model).
Jefferson JA; Johnson RJ
J Nephrol; 1999; 12(5):297-307. PubMed ID: 10630692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]